Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.58 |
| ▸ | TSHR | P16473 | 3/20 | 0.54 |
| ▸ | CETP | P11597 | 3/20 | 0.51 |
| ▸ | LTA4H | P09960 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.46 |
| ▸ | APAF1 | O14727 | 1/20 | 0.46 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.45 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7517468 | 1.00 | L3MBTL1 (0.58) | L3MBTL1TDP1TSHRCETPLTA4H | |
| SCHEMBL7120703 | 1.00 | L3MBTL1 (0.58) | L3MBTL1TDP1TSHRCETPLTA4H | |
| SCHEMBL7641859 | 1.00 | L3MBTL1 (0.58) | L3MBTL1TDP1TSHRCETPLTA4H | |
| SCHEMBL16057438 | 1.00 | L3MBTL1 (0.58) | L3MBTL1TDP1TSHRCETPLTA4H | |
| SCHEMBL14526009 | 1.00 | L3MBTL1 (0.58) | L3MBTL1TDP1TSHRCETPLTA4H | |
| SCHEMBL2886385 | 1.00 | L3MBTL1 (0.58) | L3MBTL1TDP1TSHRCETPLTA4H | |
| SCHEMBL1923328 | 1.00 | L3MBTL1 (0.58) | L3MBTL1TDP1TSHRCETPLTA4H | |
| SCHEMBL11995970 | 1.00 | L3MBTL1 (0.58) | L3MBTL1TDP1TSHRCETPLTA4H | |
| SCHEMBL21081916 | 1.00 | L3MBTL1 (0.58) | L3MBTL1TDP1TSHRCETPLTA4H | |
| SCHEMBL2231686 | 1.00 | L3MBTL1 (0.58) | L3MBTL1TDP1TSHRCETPLTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122080034-A | Polycyclic aromatic compound and organic electroluminescent element | — | 2026-05-26 | — | — | CN | disclosed |
| CN-120157693-A | Polycyclic aromatic compound and organic electroluminescent element | 爱思开新材料捷恩智株式会社 | 2025-06-17 | — | — | CN | disclosed |
| CN-120118107-A | Polycyclic aromatic compound and organic electroluminescent element | 爱思开新材料捷恩智株式会社 | 2025-06-10 | — | — | CN | disclosed |
| CN-120040479-A | Polycyclic aromatic compound and organic electroluminescent element | 爱思开新材料捷恩智株式会社 | 2025-05-27 | — | — | CN | disclosed |
| CN-119823157-A | Compound, material for organic element, ink composition, organic electroluminescent element, display device, and lighting device | 学校法人关西学院 | 2025-04-15 | — | — | CN | disclosed |
| CN-119823158-A | Compound, material for organic element, ink composition, organic electroluminescent element, display device, and lighting device | 学校法人关西学院 | 2025-04-15 | — | — | CN | disclosed |
| CN-113454093-B | Compound, material for organic element, ink composition, organic electroluminescent element, display device, and lighting device | 学校法人关西学院 | 2025-02-07 | — | — | CN | disclosed |
| CN-119219683-A | Polycyclic aromatic compound, polymer compound, material for organic device, organic electroluminescent element, display device, and lighting device | 国立大学法人京都大学 | 2024-12-31 | — | — | CN | disclosed |
| CN-119219684-A | Polycyclic aromatic compound, polymer compound, material for organic device, organic electroluminescent element, display device, and lighting device | 国立大学法人京都大学 | 2024-12-31 | — | — | CN | disclosed |
| CN-119219682-A | Polycyclic aromatic compound, polymer compound, material for organic device, organic electroluminescent element, display device, and lighting device | 国立大学法人京都大学 | 2024-12-31 | — | — | CN | disclosed |
| US-6566538-B1 | Preparation of 5-(aryloxymethyl)-g-butyrolactone derivatives | MILLENNIUM PHARMACEUTICALS, INC. | 2003-05-20 | — | — | US | disclosed |
| US-6462248-B1 | THROUGH CONVERSION, ISOMERIZATION AND/OR ADSORPTIVE SEPARATION OF AROMATIC COMPOUNDS | TORAY INDUSTRIES, INC. (JP) | 2002-10-08 | — | — | US | disclosed |
| EP-1094805-A4 | SUBSTITUTED OXYGEN ALICYCLIC COMPOUNDS, INCLUDING METHODS FOR SYNTHESIS THEREOF | MILLENNIUM PHARM INC (US) | 2002-08-28 | — | — | EP | disclosed |
| US-6433197-B1 | REACTING ARYLHYDROXY COMPOUND AND AN EPOXY COMPOUND TO FORM AN EPOXY-ARYL ETHER; REACTING EPOXY-ARYL ETHER WITH ACTIVE METHYLENE COMPOUND TO FORM A LACTONE; REDUCING TO PROVIDE HYDROXY-SUBSTITUTED TETRAHYDROFURAN | MILLENNIUM PHARMACEUTICALS, INC. | 2002-08-13 | — | — | US | disclosed |
| US-20020040154-A1 | Substituted oxygen alicyclic compounds, including methods for synthesis thereof | MILLENNIUM PHARMACEUTICALS, INC. | 2002-04-04 | — | — | US | disclosed |
| US-6306895-B1 | PREPARATION OF CYCLIC OXYGEN COMPOUNDS, INCLUDING 2,5-DISUBSTITUTED TETAHYDROFURANS, 2,6-DISUBSTITUTED TETRAHYDROPYRANS, 2,7-DISUBSTITUTED OXEPANES AND 2,8-OXOCANES. THE INVENTION ALSO PROVIDES NEW CYCLIC OXYGEN COMPOUNDS AND | MILLENIUM PHARMACEUTICALS, INC. | 2001-10-23 | — | — | US | disclosed |
| EP-1094805-A1 | SUBSTITUTED OXYGEN ALICYCLIC COMPOUNDS, INCLUDING METHODS FOR SYNTHESIS THEREOF | Millennium Pharmaceuticals, Inc. (US) | 2001-05-02 | — | — | EP | disclosed |
| EP-0985649-A2 | Method for producing an aromatic compound having an alkyl group with at least three carbon atoms | TORAY INDUSTRIES, INC. (JP) | 2000-03-15 | — | — | EP | disclosed |
| WO-2000001381-A1 | SUBSTITUTED OXYGEN ALICYCLIC COMPOUNDS, INCLUDING METHODS FOR SYNTHESIS THEREOF | LEUKOSITE, INC. (US) | 2000-01-13 | — | — | WO | disclosed |
| EP-0664316-A1 | Polycarbonate composition having improved resistance to gamma-ray radiation | TEIJIN LIMITED (JP) | 1995-07-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020040154-A1 | Substituted oxygen alicyclic compounds, including methods for synthesis thereof | OXER1, COX6C, MT-CO2 | L3MBTL1 4653/4885TDP1 3528/4885TSHR 4332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.